Observational registry following adults with chronic kidney disease in China
Follows adults with chronic kidney disease in China to study real-world outcomes.
Plain-language title generated from the registry record
Registry title: A Real World, Multi-centric, Observational Registry Study of Chronic Kidney Diseases
Key facts
- Where
- Foshan, Ganzhou, Guangzhou, Meizhou, Qingyuan, and Zhuhai, ChinaSee the 8 sites
Where in China
- The Second People's Hospital of Nanhai District in Foshan CityFoshan, ChinaNot yet recruiting
- Ganzhou Municipal HospitalGanzhou, ChinaNot yet recruiting
- Guangdong Provincial Peoples HospitalGuangzhou, ChinaTaking people
- the First Affiliated Hospital of Sun Yat-sen UniversityGuangzhou, ChinaNot yet recruiting
- Wuhua County People's HospitalMeizhou, ChinaNot yet recruiting
- Fogang County People's HospitalQingyuan, ChinaNot yet recruiting
- People's Hospital of YingdeQingyuan, ChinaNot yet recruiting
- Zhuhai Golden Bay Central HospitalZhuhai, ChinaNot yet recruiting
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Guangdong Provincial People's Hospital
- Trial code
- NCT05188885
- Record updated
- 15 January 2026
- Original description
Chronic kidney disease (CKD) refers to a variety of different diseases characterized by impairment of kidney structure and/or renal function. The prevalence of CKD in China is as high as 10.8%. With a population of more than 150 million, China has the largest number of CKD patients all over the world. People with CKD would not only progress to uremia and need renal replace treatment, it also significantly increases risk of cardiovascular disease than non-CKD population. It has created a heavy burden on people's health and national economy. There is an urgent need to establish an effective system for CKD prevention and control in China. Evidences from large sample cohort and real world based research are still rare. This study will provide good experience for reducing the occurrence and development of CKD.Read full original descriptionShow less
A Real World, Multi-centric, Observational Registry Study of Chronic Kidney Diseases
Chronic kidney disease (CKD) refers to a variety of different diseases characterized by impairment of kidney structure and/or renal function. The prevalence of CKD in China is as high as 10.8%. With a population of more than 150 million, China has the largest number of CKD patients all over the world. People with CKD would not only progress to uremia and need renal replace treatment, it also significantly increases risk of cardiovascular disease than non-CKD population. It has created a heavy burden on people's health and national economy. There is an urgent need to establish an effective system for CKD prevention and control in China. Evidences from large sample cohort and real world based research are still rare. This study will provide good experience for reducing the occurrence and development of CKD.
Inclusion: Patients diagnosed with CKD as defined in the KDIGO Clinical Practice Guidelines for the Evaluation and Management of Chronic Kidney Disease 2012 Edition; Non-CKD patients with hypertension, diabetes, hyperlipidemia, hyperuricemia, eGFR (CKD-EPI formula) of 60-89 ml/min/1.73m\^2 and other risk factors for CKD; Healthy population; Signed the informed consent voluntarily.
Exclusion: 。Patients identified to be unsuitable for enrollment by the study physician.